Literature DB >> 23085087

Expression, purification and kinetic characterisation of human tissue transglutaminase.

Isabelle Roy1, Olivia Smith, Christopher M Clouthier, Jeffrey W Keillor.   

Abstract

The expression of soluble recombinant transglutaminase (TGase) has proven to be a challenge for many research groups. Herein, we report a complementary method for the expression, in BL21(DE3) Escherichia coli, of recombinant human tissue transglutaminase (hTG2) whose solubility is enhanced through N-terminal fusion to glutathione S-transferase (GST). Moreover, we report the cleavage of the GST tag using PreScission™ Protease (PSP) and purification of hTG2 in its untagged form, distinctively suitable for subsequent studies of its remarkable conformational equilibrium. The effects of co-solvents and storage conditions on stability of purified hTG2 are also reported. Furthermore, we demonstrate for the first time the use of a convenient chromogenic assay to measure the activity of the human enzyme. The utility of this assay was demonstrated in the measurement of the kinetic parameters of a wide variety of substrates and inhibitors of both hTG2 and the extensively studied guinea pig liver TGase. Finally, comparison of these results provides further evidence for the functional similarity of the two enzymes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085087     DOI: 10.1016/j.pep.2012.10.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Continuous throughput and long-term observation of single-molecule FRET without immobilization.

Authors:  Swati Tyagi; Virginia VanDelinder; Niccolò Banterle; Gustavo Fuertes; Sigrid Milles; Morgane Agez; Edward A Lemke
Journal:  Nat Methods       Date:  2014-01-19       Impact factor: 28.547

2.  Simultaneous analysis of enzyme structure and activity by kinetic capillary electrophoresis-MS.

Authors:  Gleb G Mironov; Christopher M Clouthier; Abdullah Akbar; Jeffrey W Keillor; Maxim V Berezovski
Journal:  Nat Chem Biol       Date:  2016-09-05       Impact factor: 15.040

3.  Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.

Authors:  Ellen A Rorke; Gautam Adhikary; Henryk Szmacinski; Joseph R Lakowicz; David J Weber; Raquel Godoy-Ruiz; Purushottamachar Puranik; Jeffrey W Keillor; Eric W J Gates; Richard L Eckert
Journal:  Mol Carcinog       Date:  2021-10-05       Impact factor: 4.784

4.  Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors.

Authors:  Alana M M Rangaswamy; Pauline Navals; Eric W J Gates; Sammir Shad; Sarah K I Watt; Jeffrey W Keillor
Journal:  RSC Med Chem       Date:  2022-01-26

5.  A simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis.

Authors:  Ken Motohashi
Journal:  BMC Biotechnol       Date:  2015-06-03       Impact factor: 2.563

6.  Abrogation of Immunogenic Properties of Gliadin Peptides through Transamidation by Microbial Transglutaminase Is Acyl-Acceptor Dependent.

Authors:  Lin Zhou; Yvonne M C Kooy-Winkelaar; Robert A Cordfunke; Irina Dragan; Allan Thompson; Jan Wouter Drijfhout; Peter A van Veelen; Hongbing Chen; Frits Koning
Journal:  J Agric Food Chem       Date:  2017-08-17       Impact factor: 5.279

7.  Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.

Authors:  Kim Y P Apperley; Isabelle Roy; Vincent Saucier; Nicholas Brunet-Filion; Sara-Pier Piscopo; Christophe Pardin; Élise De Francesco; Catherine Hao; Jeffrey W Keillor
Journal:  Medchemcomm       Date:  2016-12-05       Impact factor: 3.597

8.  The complex role of transglutaminase 2 in glioblastoma proliferation.

Authors:  Soner Gundemir; Alina Monteagudo; Abdullah Akbar; Jeffrey W Keillor; Gail V W Johnson
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

9.  Biotechnological applications of transglutaminases.

Authors:  Natalie M Rachel; Joelle N Pelletier
Journal:  Biomolecules       Date:  2013-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.